Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oncometabolites in cancer aggressiveness and tumour repopulation
Ilaria Dando, Elisa Dalla Pozza, Giulia Ambrosini, et al.
Biological reviews/Biological reviews of the Cambridge Philosophical Society (2019) Vol. 94, Iss. 4, pp. 1530-1546
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Regulation of succinate dehydrogenase and role of succinate in cancer
Elisa Dalla Pozza, Ilaria Dando, Raffaella Pacchiana, et al.
Seminars in Cell and Developmental Biology (2019) Vol. 98, pp. 4-14
Closed Access | Times Cited: 158
To metabolomics and beyond: a technological portfolio to investigate cancer metabolism
Federica Danzi, Raffaella Pacchiana, Andrea Mafficini, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 108
New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects
Maohua Huang, Yuning Lin, Chenran Wang, et al.
Drug Resistance Updates (2022) Vol. 64, pp. 100849-100849
Closed Access | Times Cited: 97
2-Hydroxyglutarate in Cancer Cells
Petr Ježek
Antioxidants and Redox Signaling (2019) Vol. 33, Iss. 13, pp. 903-926
Open Access | Times Cited: 103
Ovarian Cancer Biomarkers: Moving Forward in Early Detection
Vasco D. B. Bonifácio
Advances in experimental medicine and biology (2020), pp. 355-363
Closed Access | Times Cited: 85
SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine–Glycine–One-Carbon Pathways in Cancer
Tyler Sniegowski, Ksenija Korać, Yangzom D. Bhutia, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 216-216
Open Access | Times Cited: 58
Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies
Giulia Ambrosini, Marco Cordani, Ali Zarrabi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis
Shagun Sharma, Navneet Agnihotri, Sandeep Kumar
Biochemical Pharmacology (2022) Vol. 198, pp. 114943-114943
Closed Access | Times Cited: 31
Correlation between the Warburg effect and progression of triple-negative breast cancer
Shaojun Liu, Yuxuan Li, Meng Yuan, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 20
ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy
Chenran Wang, Maohua Huang, Yuning Lin, et al.
Nature Metabolism (2023) Vol. 5, Iss. 10, pp. 1765-1786
Closed Access | Times Cited: 20
Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression
Fabiana Crispo, Valentina Condelli, Silvia Lepore, et al.
Cells (2019) Vol. 8, Iss. 8, pp. 798-798
Open Access | Times Cited: 47
Oncometabolites: A new insight for oncology
Fatemeh Khatami, Seyed Mohammad Kazem Aghamir, Seyed Mohammad Tavangar
Molecular Genetics & Genomic Medicine (2019) Vol. 7, Iss. 9
Open Access | Times Cited: 43
L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism
Miku Sato, Narumi Harada‐Shoji, Takafumi Toyohara, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 38
Epstein‐Barr virus‐driven metabolic alterations contribute to the viral lytic reactivation and tumor progression in nasopharyngeal carcinoma
Feng Shi, Shang Li, Min Zhou, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 5
Closed Access | Times Cited: 5
Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1
Carlos Sànchez‐Martìn, Daniela Menon, Elisabetta Moroni, et al.
Antioxidants and Redox Signaling (2020) Vol. 34, Iss. 7, pp. 505-516
Open Access | Times Cited: 33
Succinate-Directed Approaches for Warburg Effect-Targeted Cancer Management, an Alternative to Current Treatments?
Adrián Casas-Benito, Sonia Martínez-Herrero, Alfredo Martı́nez
Cancers (2023) Vol. 15, Iss. 10, pp. 2862-2862
Open Access | Times Cited: 11
Role of coenzymes in cancer metabolism
Maheshwor Thapa, Guido Dallmann
Seminars in Cell and Developmental Biology (2019) Vol. 98, pp. 44-53
Open Access | Times Cited: 35
The metabolomic landscape plays a critical role in glioma oncogenesis
Kenta Masui, Webster K. Cavenee, Paul S. Mischel, et al.
Cancer Science (2022) Vol. 113, Iss. 5, pp. 1555-1563
Open Access | Times Cited: 17
Succinate Pathway in Head and Neck Squamous Cell Carcinoma: Potential as a Diagnostic and Prognostic Marker
Ximena Terra, Victòria Ceperuelo‐Mallafré, Carla Merma Linares, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1653-1653
Open Access | Times Cited: 22
Oncometabolites and the response to radiotherapy
Kexu Xiang, Verena Jendrossek, Johann Matschke
Radiation Oncology (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 22
Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer
Martina Godel, Giacomo Ortone, Dario P. Anobile, et al.
Pharmaceutics (2021) Vol. 13, Iss. 5, pp. 762-762
Open Access | Times Cited: 18
Acidity‐Responsive Nanoreactors Destructed “Warburg Effect” for Toxic‐Acidosis and Starvation Synergistic Therapy
Jiawei Zhu, Hao Cai, Chengshuang Xu, et al.
Small (2023) Vol. 19, Iss. 46
Closed Access | Times Cited: 7
Cancer Alters the Metabolic Fingerprint of Extracellular Vesicles
Mari Palviainen, Kirsi Laukkanen, Zeynep Tavukcuoglu, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3292-3292
Open Access | Times Cited: 16
Metabolic Reprogramming is a Hallmark of Metabolism Itself
Miguel Ángel Medina
BioEssays (2020) Vol. 42, Iss. 10
Open Access | Times Cited: 15
Artificial intelligence uncovers carcinogenic human metabolites
Aayushi Mittal, Sanjay Kumar Mohanty, Vishakha Gautam, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 11, pp. 1204-1213
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top